[Long-term care after deep brain stimulation of patients with Parkinson's disease].
Long-term care after deep brain stimulation for Parkinson's disease requires regular technical check-ups as well as clinical follow-up. Residual or emerging difficulties with gait, balance or speech should be addressed by specific rehabilitation programs. In cases of psychosocial maladjustment, psychotherapy or family counseling may prove helpful. After consolidation of stimulation parameters, pharmacotherapy can be tailored according to the individual needs, following the same guidelines as for Parkinson's disease patients without deep brain stimulation. In cases of clinical deterioration, malfunctioning of the stimulation system, comorbidity or disease progression has to be considered and treated accordingly. Structured long-term care programs may contribute to patient satisfaction and ensure quality of life.
Sixel-Döring
F
F
Paracelsus-Elena-Klinik, Klinikstrasse 16, Kassel, Germany. friederike.sixel@pk-mx.de
Ebersbach
G
G
D000359:Aftercare / Q000379:methods* / Q000523:psychology; D000978:Antiparkinson Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D046690:Deep Brain Stimulation / Q000009:adverse effects / Q000379:methods*; D018450:Disease Progression; D005196:Family Therapy; D005917:Globus Pallidus / Q000503:physiopathology; D006801:Humans; D008134:Long-Term Care / Q000379:methods / Q000523:psychology; D010300:Parkinson Disease / Q000503:physiopathology / Q000523:psychology / Q000628:therapy*; D010353:Patient Education as Topic; D017060:Patient Satisfaction; D026741:Physical Therapy Modalities; D011613:Psychotherapy; D011788:Quality of Life / Q000523:psychology; D012917:Social Adjustment; D020531:Subthalamic Nucleus / Q000503:physiopathology
D000978:Antiparkinson Agents